Outcome estimation of treatments for target individuals is an important foundation for decision making based on causal relations. Most existing outcome estimation methods deal with binary or multiple-choice treatments; however, in some applications, the number of treatments can be significantly large, while the treatments themselves have rich information. In this study, we considered one important instance of such cases: the outcome estimation problem of graph-structured treatments such as drugs. Owing to the large number of possible treatments, the counterfactual nature of observational data that appears in conventional treatment effect estimation becomes more of a concern for this problem. Our proposed method, GraphITE (pronounced "graphite") learns the representations of graph-structured treatments using graph neural networks while mitigating observation biases using Hilbert-Schmidt Independence Criterion regularization, which increases the independence of the representations of the targets and treatments. Experiments on two real-world datasets show that GraphITE outperforms baselines, especially in cases with a large number of treatments.
翻译:对目标个人治疗结果进行估计是基于因果关系的决策的重要基础。大多数现有结果估计方法涉及二进制或多种选择治疗;然而,在某些应用中,治疗数量可能非常大,而治疗本身则有丰富的信息。在本研究中,我们考虑了这类案例的一个重要实例:如药物等图表结构化治疗的结果估计问题。由于可能治疗数量众多,常规治疗效果估计中出现的观测数据的反事实性质更引起对这一问题的关注。我们拟议的方法,GreatITE(已宣布的“绘图”)利用图象神经网络了解图表结构治疗的表示,同时利用Hilbert-Schmidt独立性标准规范来减轻观察偏差,这提高了目标和治疗形式的独立性。关于两个真实世界数据集的实验表明,GreatITE超越了基线,特别是在大量治疗的情况下。